4-25667908-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_006424.3(SLC34A2):āc.552T>Cā(p.Ile184=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0272 in 1,612,818 control chromosomes in the GnomAD database, including 788 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.022 ( 78 hom., cov: 32)
Exomes š: 0.028 ( 710 hom. )
Consequence
SLC34A2
NM_006424.3 synonymous
NM_006424.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.122
Genes affected
SLC34A2 (HGNC:11020): (solute carrier family 34 member 2) The protein encoded by this gene is a pH-sensitive sodium-dependent phosphate transporter. Phosphate uptake is increased at lower pH. Defects in this gene are a cause of pulmonary alveolar microlithiasis. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 4-25667908-T-C is Benign according to our data. Variant chr4-25667908-T-C is described in ClinVar as [Benign]. Clinvar id is 403455.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-25667908-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.122 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.022 (3346/152292) while in subpopulation NFE AF= 0.0305 (2074/68026). AF 95% confidence interval is 0.0294. There are 78 homozygotes in gnomad4. There are 1666 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 78 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC34A2 | NM_006424.3 | c.552T>C | p.Ile184= | synonymous_variant | 6/13 | ENST00000382051.8 | NP_006415.3 | |
SLC34A2 | NM_001177998.2 | c.549T>C | p.Ile183= | synonymous_variant | 6/13 | NP_001171469.2 | ||
SLC34A2 | NM_001177999.2 | c.549T>C | p.Ile183= | synonymous_variant | 6/13 | NP_001171470.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC34A2 | ENST00000382051.8 | c.552T>C | p.Ile184= | synonymous_variant | 6/13 | 1 | NM_006424.3 | ENSP00000371483 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0220 AC: 3346AN: 152174Hom.: 78 Cov.: 32
GnomAD3 genomes
AF:
AC:
3346
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0217 AC: 5446AN: 251430Hom.: 83 AF XY: 0.0220 AC XY: 2992AN XY: 135888
GnomAD3 exomes
AF:
AC:
5446
AN:
251430
Hom.:
AF XY:
AC XY:
2992
AN XY:
135888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0277 AC: 40464AN: 1460526Hom.: 710 Cov.: 30 AF XY: 0.0271 AC XY: 19677AN XY: 726624
GnomAD4 exome
AF:
AC:
40464
AN:
1460526
Hom.:
Cov.:
30
AF XY:
AC XY:
19677
AN XY:
726624
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0220 AC: 3346AN: 152292Hom.: 78 Cov.: 32 AF XY: 0.0224 AC XY: 1666AN XY: 74466
GnomAD4 genome
AF:
AC:
3346
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
1666
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
26
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at